{"transactions":[{"id":784129,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48235,"kind":"person","name":"Opipari Anthony W.","position":1,"cik":"0002131341","reported_name":"Opipari Anthony W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series D Warrants (Right to Buy)","published_at":"2026-05-12T00:30:04.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":5263,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The warrants to purchase shares of common stock were automatically exercised into shares of Common Stock by their terms immediately prior to the closing of the Issuer's initial public offering on a net exercise basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The warrants to purchase shares of common stock were automatically exercised into shares of Common Stock by their terms immediately prior to the closing of the Issuer's initial public offering on a net exercise basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The warrants to purchase shares of common stock were automatically exercised into shares of Common Stock by their terms immediately prior to the closing of the Issuer's initial public offering on a net exercise basis."}],"balance_after":0,"derivative":{"exercise_price":0.1,"underlying":"Common Stock","underlying_shares":541},"source":{"system":"sec-edgar","filing":"0001193125-26-217584","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1882782/000119312526217584/ownership.xml","form_type":"4"}},{"id":784128,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48235,"kind":"person","name":"Opipari Anthony W.","position":1,"cik":"0002131341","reported_name":"Opipari Anthony W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-12T00:30:04.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":27777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Option vests upon the first occurrence of the total market capitalization of the Issuer being equal to or in excess of $1,500,000,000, based on a 5-day volume-weighted average price of a share of Common Stock as traded on the Nasdaq Capital Market, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":27777,"derivative":{"exercise_price":18,"expiration_date":"2036-05-06","underlying":"Common Stock","underlying_shares":27777},"source":{"system":"sec-edgar","filing":"0001193125-26-217584","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1882782/000119312526217584/ownership.xml","form_type":"4"}},{"id":784127,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48235,"kind":"person","name":"Opipari Anthony W.","position":1,"cik":"0002131341","reported_name":"Opipari Anthony W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-12T00:30:04.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":250203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Option vests in forty-eight (48) equal monthly installments, with the first installment scheduled to vest on June 7, 2026, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":250203,"derivative":{"exercise_price":18,"expiration_date":"2036-05-06","underlying":"Common Stock","underlying_shares":250203},"source":{"system":"sec-edgar","filing":"0001193125-26-217584","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1882782/000119312526217584/ownership.xml","form_type":"4"}},{"id":784126,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48235,"kind":"person","name":"Opipari Anthony W.","position":1,"cik":"0002131341","reported_name":"Opipari Anthony W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series D Convertible Preferred Stock","published_at":"2026-05-12T00:30:04.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":17545,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F7","text":"Gives effect to the 1-for-9.7170 reverse stock split effected prior to the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1806},"source":{"system":"sec-edgar","filing":"0001193125-26-217584","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1882782/000119312526217584/ownership.xml","form_type":"4"}},{"id":784125,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48235,"kind":"person","name":"Opipari Anthony W.","position":1,"cik":"0002131341","reported_name":"Opipari Anthony W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series C Convertible Preferred Stock","published_at":"2026-05-12T00:30:04.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series C Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series C Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series C Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series C Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F7","text":"Gives effect to the 1-for-9.7170 reverse stock split effected prior to the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2058},"source":{"system":"sec-edgar","filing":"0001193125-26-217584","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1882782/000119312526217584/ownership.xml","form_type":"4"}},{"id":784124,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48235,"kind":"person","name":"Opipari Anthony W.","position":1,"cik":"0002131341","reported_name":"Opipari Anthony W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series B Convertible Preferred Stock","published_at":"2026-05-12T00:30:04.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":11083,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series B Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.2837 basis for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series B Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.2837 basis for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series B Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.2837 basis for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series B Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.2837 basis for no additional consideration."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F7","text":"Gives effect to the 1-for-9.7170 reverse stock split effected prior to the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1194},"source":{"system":"sec-edgar","filing":"0001193125-26-217584","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1882782/000119312526217584/ownership.xml","form_type":"4"}},{"id":784123,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48235,"kind":"person","name":"Opipari Anthony W.","position":1,"cik":"0002131341","reported_name":"Opipari Anthony W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series A Convertible Preferred Stock","published_at":"2026-05-12T00:30:04.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":18531,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series A Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series A Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series A Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F7","text":"Gives effect to the 1-for-9.7170 reverse stock split effected prior to the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1907},"source":{"system":"sec-edgar","filing":"0001193125-26-217584","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1882782/000119312526217584/ownership.xml","form_type":"4"}},{"id":784122,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48235,"kind":"person","name":"Opipari Anthony W.","position":1,"cik":"0002131341","reported_name":"Opipari Anthony W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-12T00:30:04.000Z","date":"2026-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":4,"price":18,"value":72.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The warrants to purchase shares of common stock were automatically exercised into shares of Common Stock by their terms immediately prior to the closing of the Issuer's initial public offering on a net exercise basis."},{"field":"shares","element":"transactionShares","label":"F6","text":"Pursuant to the terms of the warrants, the Issuer withheld 4 warrant shares to pay the exercise price in connection with the net exercise."}],"balance_after":7502,"source":{"system":"sec-edgar","filing":"0001193125-26-217584","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1882782/000119312526217584/ownership.xml","form_type":"4"}},{"id":784121,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48235,"kind":"person","name":"Opipari Anthony W.","position":1,"cik":"0002131341","reported_name":"Opipari Anthony W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-12T00:30:04.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":541,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The warrants to purchase shares of common stock were automatically exercised into shares of Common Stock by their terms immediately prior to the closing of the Issuer's initial public offering on a net exercise basis."}],"balance_after":7506,"source":{"system":"sec-edgar","filing":"0001193125-26-217584","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1882782/000119312526217584/ownership.xml","form_type":"4"}},{"id":784120,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48235,"kind":"person","name":"Opipari Anthony W.","position":1,"cik":"0002131341","reported_name":"Opipari Anthony W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-12T00:30:04.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":6965,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series A Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series B Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.2837 basis for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series C Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."}],"balance_after":6965,"source":{"system":"sec-edgar","filing":"0001193125-26-217584","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1882782/000119312526217584/ownership.xml","form_type":"4"}}]}